Aims Patients with non-ischemic systolic heart failure have an increased risk of sudden
cardiac death (SCD). Myocardial fibrosis, detected as late gadolinium enhancement (LGE) …

Objectives: The purpose of this study was to evaluate the association between regional
myocardial fibrosis and ventricular arrhythmias in patients with cardiomyopathy …

Importance Risk stratification of patients with nonischemic dilated cardiomyopathy is
primarily based on left ventricular ejection fraction (LVEF). Superior prognostic factors may …

Ventricular Fibrosis in Patients With NICM Background Current guidelines recommend the
implantation of an implantable cardioverter‐defibrillator (ICD) for primary prevention of …

Background The majority of sudden cardiac death (SCD) in patients with heart failure occurs
in those with mild‐moderate left ventricular (LV) systolic dysfunction (LVEF 36–50%) who …

Background The use of cardiac magnetic resonance imaging (c-MRI) in risk stratification for
clinical outcomes of patients with ischemic cardiomyopathy (ICM) remains low. This …

Background: Myocardial fibrosis (MF) is a risk factor for poor prognosis in dilated
cardiomyopathy (DCM). Late gadolinium enhancement (LGE) of the myocardium on cardiac …

Objectives The purpose of this study was to assess whether the presence and extent of
fibrosis changes over time in patients with nonischemic, dilated cardiomyopathy (DCM) …

The mechanism of sudden cardiac death (SCD) in patients with nonischemic dilated
cardiomyopathy (NIDCM) is mostly due to sustained ventricular tachycardia and ventricular …

Objectives: The goal of this study was to explore whether fibrosis detected by late
gadolinium enhancement cardiac magnetic resonance (LGE-CMR) is an independent …